Post-Traumatic Headache

Phase 4 trials (9)

• sumatriptan
• galantamine
• metoclopramide
• naproxen
• naratriptan
• prazosin
• dexamethasone
• galcanezumab-gnlm
• abobotulinumtoxinA

Phase 3 trials (4)

• diclofenac
• eptinezumab
• petrolatum, white
• diphenhydramine

Phase 2 trials (4)

• amitriptyline
• fremanezumab
• rimabotulinumtoxinB
• erenumab

Phase 1 trials (2)

• bupivacaine
• psilocybin

Other trials (11)

• pituitary adenylate cyclase-activating polypeptide-38
• acetaminophen
• lidocaine
• tizanidine
• calcitonin gene related peptide
• fentanyl
• cilostazol
• sildenafil
• morphine
• maxipost
• levcromakalim

Organization Involved with Phase 4 Indications (12)

• Ipsen
• Clinvest
• GlaxoSmithKline
• United States Army
• University of Washington
• Lancaster General Hospital
• University of British Columbia
• University of California, Los Angeles
• The New England Center for Headache
• Department of Veteran Affairs
• Johnson and Johnson
• Allergan PLC (2015)

Organization Involved with Phase 3 Indications (1)

• Yeshiva University

Organization Involved with Phase 2 Indications (10)

• Amgen
• Novartis
• Teva
• University of Arizona
• Arizona State University
• Norwegian University of Science and Technology
• Mayo Clinic
• University of Copenhagen
• Department of Defense
• TGen Drug Development

Organization Involved with Phase 1 Indications (1)

• Yale University

Organization Involved with Other Experimental Indications (4)

• Merck
• Henry M. Jackson Foundation for the Advancement of Military Medicine
• Medical College of Wisconsin
• University of Monastir